CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Operating Leases (2024 - 2026)

CDT Equity's (CDT) quarterly Operating Leases came in at $100000.0 in Q1 2026, up 28.21% YoY from $78000.0 in Q1 2025, and down 13.04% on a QoQ basis from $115000.0 in Q4 2025.

CDT Equity (CDT) Operating Leases (2024 - 2026) Analysis & Trends

CDT Equity (CDT) has 3 years of Operating Leases data on file, last reported at $100000.0 in Q1 2026.

  • Quarterly Operating Leases rose 28.21% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 28.21% YoY) and the FY2025 annual result came in at $115000.0, up 7.48% from the prior year.
  • Operating Leases slipped to $100000.0 in Q1 2026, from $115000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $171000.0 in Q1 2024 to a low of $8000.0 in Q3 2025.
  • A 3-year average of $97333.3 and a median of $107000.0 in 2024 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2025 — Operating Leases tumbled 92.73% — and 2026, when it climbed 28.21%.
  • Tracing CDT's Operating Leases over 3 years: stood at $107000.0 in 2024, then grew by 7.48% to $115000.0 in 2025, then retreated by 13.04% to $100000.0 in 2026.
  • The last three Operating Leases figures came in at $100000.0 (Q1 2026), $115000.0 (Q4 2025), and $8000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CDT Equity 1.55 Mn 1.55 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 115,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 46,000.00
Mar 31, 2025 78,000.00
Dec 31, 2024 107,000.00
Sep 30, 2024 110,000.00
Jun 30, 2024 141,000.00
Mar 31, 2024 171,000.00